Internal Medicine, Pulmonary Disease · West Allis, WI
NPI
1588637672
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
2424 S 90th St
West Allis, WI, 53227
Phone (414) 328-8150
Groups this clinician bills Medicare through
Medicare paid, 2024
$124K
2,333 services
Medicare patients, 2024
703
Average age 72
Drug cost, 2024
$1.9M
4,360 prescriptions
Company payments, 2025
$159
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael E Flatley was code 99214 (office e&m - established), 359 times for 303 patients. In total Michael E Flatley billed 2,333 services in 28 codes, and Medicare paid $124K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-11-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 359 | 303 | $83.73 | $30K |
| J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | Office | 318 | 97 | $0.03 | $10.99 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 297 | 206 | $11.97 | $3,556 |
| 99215 Office E&M - Established | Office | 242 | 173 | $123.84 | $30K |
| 99233 Hospital E&M - Subsequent | Facility | 157 | 67 | $86.52 | $14K |
| G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 117 | 115 | $28.28 | $3,309 |
| 94726 Pulmonary Function Testing | Office | 113 | 108 | $38.53 | $4,354 |
| 94729 Pulmonary Function Testing | Office | 113 | 107 | $38.36 | $4,335 |
| 94060 Pulmonary Function Testing | Office | 112 | 103 | $27.40 | $3,069 |
| 99204 Office E&M - New | Office | 70 | 70 | $106.72 | $7,470 |
| 94729 Pulmonary Function Testing | Facility | 57 | 56 | $5.96 | $340 |
| 94726 Pulmonary Function Testing | Facility | 56 | 55 | $8.06 | $451 |
| 94060 Pulmonary Function Testing | Facility | 54 | 53 | $6.86 | $371 |
| 99203 Office E&M - New | Office | 41 | 41 | $67.77 | $2,779 |
| 99223 Hospital E&M - Initial | Facility | 41 | 37 | $120.47 | $4,939 |
By year: 2022 $131K for 1,858 services; 2023 $129K for 2,012 services; 2024 $124K for 2,333 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael E Flatley prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 986 prescriptions and refills. In total Michael E Flatley wrote 4,360 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 986 | 1,269 | 202 | $810K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 461 | 607 | 188 | $15K |
| Prednisone Generic | 260 | 318 | 97 | $865 |
| Breo Ellipta Fluticasone/Vilanterol | 245 | 376 | 51 | $148K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 187 | 263 | 41 | $121K |
| Symbicort Budesonide/Formoterol Fumarate | 184 | 303 | 40 | $69K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 160 | 267 | 43 | $30K |
| Spiriva Respimat Tiotropium Bromide | 118 | 202 | 25 | $104K |
| Arnuity Ellipta Fluticasone Furoate | 108 | 126 | 24 | $31K |
| Montelukast Sodium Generic | 107 | 283 | 29 | $775 |
| Roflumilast Generic | 105 | 165 | 27 | $8,500 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 100 | 130 | 22 | $61K |
| Trazodone Hcl Generic | 92 | 150 | 24 | $713 |
| Spiriva Handihaler Tiotropium Bromide | 85 | 143 | 20 | $73K |
| Ventolin Hfa Albuterol Sulfate | 82 | 88 | 27 | $5,035 |
Brand drugs: 2,877 claims; generic drugs: 1,483 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael E Flatley $159 ($159 in general payments such as food, travel and fees) from 2 companies. The largest payer was Novo Nordisk Inc with $125.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 1 | $125 |
| Itamar Medical Inc | 1 | $33.67 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.